慢性亚托皮肤炎与埃索诺菲利亚通过Daesiho-Tang改善:一个病例报告
Min-Cheol Park1,2, Ju-Hyun Lee3, Eun-Jin Seong4
1Department of Korean Medicine Ophthalmology and Otolaryngology and Dermatology, Wonkwang University Korean Medicine Hospital, Iksan, Jeollabuk-do, 54538, Republic of Korea.
Clinical, cosmetic and investigational dermatology
|September 26, 2023
概括
这种案例研究表明,Daesiho-tang (DSHT) 有效地治疗了对标准疗法无反应的带有eosinophilia的慢性无性皮炎 (AD). DSHT改善了皮肤病变,和乙素水平,表明其作为AD治疗替代方案的潜力.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 草药是一种草药.
背景情况:
- 慢性亚托皮性皮肤炎 (AD) 带有埃索诺菲利亚往往会带来治疗挑战.
- 对于严重或耐火病例,传统疗法可能不足.
研究的目的:
- 报告慢性亚托皮性皮肤炎 (AD) 病例与eosinophilia.
- 为了评估Daesiho-tang (DSHT) 在对常规治疗无反应的患者的疗效.
主要方法:
- 一名患有慢性AD和eosinophilia的患者接受了DSHT.
- 临床结果的评估是使用Scoring Atopic Dermatitis (SCORAD),皮肤病生命质量指数 (DLQI) 和伴随系统性症状 (ASS) 的方法进行的.
- 监测了实验室检测,包括外围血液中乙酸细胞计数和总IgE.
主要成果:
- DSHT显著改善了SCORAD分数从62.9到23.5和DLQI分数从19到5.
- 乙氨基酸水平从17.2%降至4.5%,并随之而来的全身症状有所改善.
- 总IgE水平略有下降,肝酶 (AST,ALT) 正常化.
结论:
- 戴西霍-唐 (DSHT) 显示出具有重要的治疗潜力,用于慢性亚托邦性皮肤炎与eosinophilia.
- 对于耐火性AD患者来说,DSHT可能是可行的替代治疗选择.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
326
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
326
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K